Lv L, Zhang H, Tan J, Wang C
Cell Commun Signal. 2025; 23(1):129.
PMID: 40065349
PMC: 11892234.
DOI: 10.1186/s12964-025-02136-9.
Bochkova Z, Baizhumanov A, Yusipovich A, Morozova K, Nikelshparg E, Fedotova A
Biophys Rev. 2025; 17(1):55-88.
PMID: 40060020
PMC: 11885220.
DOI: 10.1007/s12551-025-01270-5.
Lang J, Xiong Z
Biomed Rep. 2025; 22(4):64.
PMID: 39991000
PMC: 11843190.
DOI: 10.3892/br.2025.1942.
Xue X, Wang Z, Qi Y, Chen N, Zhao K, Zhao M
J Glob Health. 2025; 15:04051.
PMID: 39981636
PMC: 11843521.
DOI: 10.7189/jogh.15.04051.
Wang C, Yuan C
Mol Neurobiol. 2025; .
PMID: 39838179
DOI: 10.1007/s12035-025-04691-1.
Neuroprotective effects of GLP-1 class drugs in Parkinson's disease.
Lv D, Feng P, Guan X, Liu Z, Li D, Xue C
Front Neurol. 2024; 15:1462240.
PMID: 39719978
PMC: 11667896.
DOI: 10.3389/fneur.2024.1462240.
Brain-wide alterations revealed by spatial transcriptomics and proteomics in COVID-19 infection.
Zhang T, Li Y, Pan L, Sha J, Bailey M, Faure-Kumar E
Nat Aging. 2024; 4(11):1598-1618.
PMID: 39543407
PMC: 11867587.
DOI: 10.1038/s43587-024-00730-z.
Interplay of α-Synuclein Oligomers and Endoplasmic Reticulum Stress in Parkinson'S Disease: Insights into Cellular Dysfunctions.
Zeng H, Liu Y, Liu X, Li J, Lu L, Xue C
Inflammation. 2024; .
PMID: 39382817
DOI: 10.1007/s10753-024-02156-6.
Mapping the research of mitochondria and Parkinson's disease: a bibliometric analysis.
Chen Y, Xie M, Zhou S, Liu F
Front Neurol. 2024; 15:1413762.
PMID: 39350973
PMC: 11439651.
DOI: 10.3389/fneur.2024.1413762.
-Associated Parkinson's Disease Is a Distinct Entity.
Skrahin A, Horowitz M, Istaiti M, Skrahina V, Lukas J, Yahalom G
Int J Mol Sci. 2024; 25(13).
PMID: 39000225
PMC: 11241486.
DOI: 10.3390/ijms25137102.
Regulated cell death in hypoxic-ischaemic encephalopathy: recent development and mechanistic overview.
Wu L, Chang E, Zhao H, Ma D
Cell Death Discov. 2024; 10(1):277.
PMID: 38862503
PMC: 11167026.
DOI: 10.1038/s41420-024-02014-2.
Risk of Parkinson's disease among users of alpha-adrenergic receptor antagonists: a systematic review and meta-analysis.
Lamichhane P, Tariq A, Akhtar A, Raza M, Lamsal A, Agrawal A
Ann Med Surg (Lond). 2024; 86(6):3409-3415.
PMID: 38846867
PMC: 11152853.
DOI: 10.1097/MS9.0000000000002117.
Oxidative Stress and Neurodegeneration: Insights and Therapeutic Strategies for Parkinson's Disease.
Bej E, Cesare P, Volpe A, dAngelo M, Castelli V
Neurol Int. 2024; 16(3):502-517.
PMID: 38804477
PMC: 11130796.
DOI: 10.3390/neurolint16030037.
Unraveling the Ties: Type 2 Diabetes and Parkinson's Disease - A Nano-Based Targeted Drug Delivery Approach.
De S, Banerjee S, Rakshit P, Banerjee S, Kumar S
Curr Diabetes Rev. 2024; 21(6):32-58.
PMID: 38747222
DOI: 10.2174/0115733998291968240429111357.
Biochemical properties and biological potential of Syzygium heyneanum with antiparkinson's activity in paraquat induced rodent model.
Saadullah M, Tariq H, Chauhdary Z, Saleem U, Bukhari S, Sehar A
PLoS One. 2024; 19(3):e0298986.
PMID: 38551975
PMC: 10980224.
DOI: 10.1371/journal.pone.0298986.
Quantifying nanoscopic alterations associated with mitochondrial dysfunction using three-dimensional single-molecule localization microscopy.
Brenner B, Xu F, Zhang Y, Kweon J, Fang R, Sheibani N
Biomed Opt Express. 2024; 15(3):1571-1584.
PMID: 38495683
PMC: 10942681.
DOI: 10.1364/BOE.510351.
Transcranial photobiomodulation for brain diseases: review of animal and human studies including mechanisms and emerging trends.
Lin H, Li D, Zhu J, Liu S, Li J, Yu T
Neurophotonics. 2024; 11(1):010601.
PMID: 38317779
PMC: 10840571.
DOI: 10.1117/1.NPh.11.1.010601.
Role of the P2 × 7 receptor in neurodegenerative diseases and its pharmacological properties.
Hu Z, Luo Y, Zhu J, Jiang D, Luo Z, Wu L
Cell Biosci. 2023; 13(1):225.
PMID: 38093352
PMC: 10720200.
DOI: 10.1186/s13578-023-01161-w.
The risk of Parkinson's disease in diabetic people: an updated systematic review and meta-analysis.
Azami M, Moradkhani A, Afraie M, Khateri S, Sharifian E, Zamani K
Acta Neurol Belg. 2023; 124(3):775-790.
PMID: 37982931
DOI: 10.1007/s13760-023-02424-6.
Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson's disease mouse model.
Fang T, Sun Y, Pearce A, Eleuteri S, Kemp M, Luckhurst C
Nat Commun. 2023; 14(1):7295.
PMID: 37957154
PMC: 10643470.
DOI: 10.1038/s41467-023-42876-1.